The Wound Biologics market is expected to grow from an estimated USD 2152.5 million in 2024 to USD 3730.3 million in 2033 at a CAGR of 6.30%.
With the increasing global incidence of diabetes, the wound care biologics market is predicted to grow significantly since diabetic individuals are more likely to develop diabetic ulcers. For example, the prevalence of diabetes is rising across all age...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek